Accepted for/Published in: JMIR Formative Research
Date Submitted: Feb 22, 2022
Date Accepted: Sep 12, 2022
Acceptability and Usability of a Reward-Based Mobile App for Opioid Treatment Settings: Mixed Methods Pilot Study
ABSTRACT
Background:
Contingency management is an evidence-based yet underutilized approach for opioid use disorder (OUD). The reasons for limited adoption in real-world practice include ethical, moral, and philosophical concerns regarding use of monetary incentives, and lack of technological innovation. In light of surging opioid overdose deaths, there is a need for development of technology-enabled solutions leveraging the power of contingency management in a way that is viewed by both patients and providers as acceptable and feasible.
Objective:
This mixed methods study sought to determine the perceived acceptability and usability of PROCare, a reward-based, technology-enabled recovery monitoring smartphone app designed to automate contingency management by immediately delivering micro payments to patients for achieving recovery goals via smart debit card with blocking capabilities.
Methods:
Participants included patients (n = 10) receiving buprenorphine for OUD and licensed prescribers (n = 5). Qualitative interviews were conducted by two PhD-level researchers via video conferencing to explore a priori hypotheses. Thematic analysis of interviews was conducted and synthesized into major themes.
Results:
Participants were overwhelmingly in favor of micro rewards (e.g., $1) to incentivize treatment participation (up to $150 monthly). Participants reported high acceptability of the planned debit card spending restrictions (blocking cash withdrawals and purchases at bars/liquor stores, casinos/online gambling). Quantitative data revealed a high level of perceived usability of PROCare.
Conclusions:
Patients and providers alike appear receptive to micro financial incentives in standard OUD treatment practices. Further pilot testing of PROCare is underway to determine acceptability, feasibility, and preliminary effectiveness in a rigorous randomized controlled trial.
Citation
Per the author's request the PDF is not available.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.